Can serum thyroglobulin levels predict patient outcome after treatment of differentiated thyroid carcinoma?

scientific article published on 22 May 2007

Can serum thyroglobulin levels predict patient outcome after treatment of differentiated thyroid carcinoma? is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/NCPENDMET0532
P698PubMed publication ID17519916

P50authorSteven I. ShermanQ43011758
P2860cites workBiomarkers and surrogate endpoints: preferred definitions and conceptual frameworkQ28203935
A single recombinant human thyrotropin-stimulated serum thyroglobulin measurement predicts differentiated thyroid carcinoma metastases three to five years laterQ40411768
Surrogate end points in clinical trials: are we being misled?Q41117631
Monitoring thyroglobulin in a sensitive immunoassay has comparable sensitivity to recombinant human tsh-stimulated thyroglobulin in follow-up of thyroid cancer patientsQ79319487
Management guidelines for patients with thyroid nodules and differentiated thyroid cancerQ82293286
P433issue7
P921main subjectthyroglobulinQ20817224
P304page(s)510-511
P577publication date2007-05-22
P1433published inNature Clinical Practice Endocrinology and MetabolismQ15750240
P1476titleCan serum thyroglobulin levels predict patient outcome after treatment of differentiated thyroid carcinoma?
P478volume3

Search more.